Tumor Metabolic Diversity Predicts Lymphoma Outcomes
In a significant advancement in cancer prognosis, recent research has elucidated the pivotal role of tumor metabolic heterogeneity (MH) assessed through 18-fluorine fluorodeoxyglucose positron emission...
















